Solventum SOLV MedSurg — Operating Expenses

Other segment segments

Similar metrics at other companies

BSXMedSurg — Selling, general and administrative expenses

$557M+8.8%

BSXMedSurg — Cost of products sold

$478M+9.9%

BSXMedSurg — Segment operating income, percentage of net sale

31.3%-2.0pp

BSXMedSurg — Operating Income (Loss), Adjusted

$533M-0.6%

BSXMedSurg — Selling, general and administrative expenses, percentage of net sale

32.8%+1.0pp

BSXMedSurg — Cost of products sold, percentage of net sale

28.1%+1.1pp

Questions, answered.

What is Solventum's medsurg — operating expenses?

Solventum (SOLV) reported medsurg — operating expenses of $451M in Q1 2026.

How has Solventum's medsurg — operating expenses changed year-over-year?

Solventum's medsurg — operating expenses increased by 11.6% year-over-year, from $404M to $451M.

What is the long-term trend for Solventum's medsurg — operating expenses?

Over 3 years (2022 to 2025), Solventum's medsurg — operating expenses has grown at a 3.6% compound annual growth rate (CAGR), from $1.44B to $1.6B.

What does medsurg — operating expenses mean?

The indirect costs of operating the MedSurg business, excluding production costs.

How do you interpret medsurg — operating expenses?

Lower expenses relative to revenue suggest better operational leverage and cost control.

How does medsurg — operating expenses compare across companies?

Standard operating expense (OPEX) metric used to evaluate segment-level overhead efficiency.